Policy Details

LB77 – Adopt the Ensuring Transparency in Prior Authorization Act and Provide for Insurance and Medicaid Coverage of Biomarker Testing

Date Passed

6/6/2025

Effective Date

1/1/2026

Summary

Comprehensive prior-authorization reform: adverse prior authorization determinations must be made by a physician (or clinical peer for non-physician requests), appeals reviewed by a same/similar-specialty physician, uniform PA forms, and firm timelines. Functionally prevents automated/AI-only denials.

Healthcare Implications

Requires human clinical accountability in utilization management decisions and speeds determinations, reshaping payer/UM vendor automation; providers gain clearer escalation paths and deemed-approved protections if timelines are missed.

Impact Level

High

Keywords

Safety & Risk; Transparency & Governance

Stakeholders

Payers & Purchasers; Providers & Health Systems; Patients & Public; Regulators & Government